Healthy volunteer
Conditions
Interventions
Intake of test-food (4 tablets) with (lukewarm) water, once daily after breakfast, for 4 weeks.
Sponsors
DKS Co. Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Age: from 40 to 69 years-old 2. Individuals who are healthy and are not received treatment of disease 3. Individual who are aware of menopausal symptoms (ex. fatigue, lethargy, anxiety, palpitation, or breathlessness ) 4. Individuals whose written informed consent has been obtained 5. Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: 1. Individuals using medical products 2. Individuals with a history of mental illness, sleep apnoea, hypertension, diabetes, taste disorder, anaemia, dyslipidaemia or treatment for a serious illness in the past one year 3. Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease 4. Individuals who are a patient or have a history of or endocrine disease 5. Individuals who use a drug to treat a disease in the past 1 month 6. Individuals who are sensitive to test product or other foods, and medical products 7. Individuals who have a habit of or have been in a habit of continuously consumption of health-promoting foods, health foods or supplements containing high levels of ingredients that have been implied to have effects similar to those of the test product within the past one month, or who plan ingest these products during the test period 8. Individuals who are pregnant or lactating, and females who could become pregnant or lactating during test period 9. Individuals who are participating the other clinical tests. Individuals who participated within 3-month prior to the current study 10. Individuals who are unable to come to the facility on the designated examination date 11. Individuals who do not comply with instructions from the doctor or medical staff 12. Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sex hormone testing and Simplified Menopause Index (SMI) (after 4 weeks intervention) | — |
Countries
Japan
Contacts
Public ContactDaisuke Saito
DKS Co. Ltd General Manager R&D Department Life Sciences Headquarters
Outcome results
None listed